Proficiency Testing

Proficiency testing scheme SKML

Adalimumab (PK and ADA), infliximab (PK and ADA), vedolizumab (PK)

SKML – Scheme

Proficiency testing scheme Sanquin, ‘Round robin’

Bioanalysis@sanquin.nl

Certolizumab (PK)

Dupilumab (PK)

Golimumab (PK, ADA)

Natalizumab (PK, ADA)

Rituximab (PK, ADA)

Tocilizumab (PK)

Ustekinumab (PK, ADA)

Vedolizumab (ADA)

International standards biologics:

rituximab, infliximab, adalimumab, bevacizumab, trastuzumab, cetuximab

NIBSC – Sub category listing

Etanercept

TNF Rec II- FC Fusion protein (1st International Standard) (nibsc.org)

International standards antidrug antibodies to biologics:

infliximab

NIBSC – Sub category listing

EQA Organisations

Scottish Biological Drug Monitoring Service – NHSGGC

NEQAS:  Home – UK NEQAS | External Quality Assessment Services

CTCB: https://www.ctcb.com/

GECLID:    https://www.geclid.es/

Biologie Perspective: www.biologie-prospective.org